Anker Gunvald Lundemose

Anker Gunvald Lundemose was the founder of Servier Symphogen A, founded in 2000, where the title held was Director.
Dr. Lundemose was the founder of Saniona AB, founded in 2011, where the title held was Director.
Dr. Lundemose is the founder of Aniona ApS, founded in 2012, where the title held is Director.
Dr. Lundemose is also the founder of RICC A..
Dr. Lundemose is Chief Executive Officer at BioTesch Advice & Consultancy.
Dr. Lundemose is Director at MISSION Therapeutics Ltd. Dr. Lundemose is Director at Saniona A. Dr. Lundemose is Director at Antag Therapeutics ApS.
Dr. Lundemose is Member-Supervisory Board at Inthera Bioscience AG.
Dr. Lundemose was Chief Executive Officer at Pantheco A from 1998 to 2003.
Dr. Lundemose was President & Chief Executive Officer at Bionor Pharma ASA from 2013 to 2015.
Dr. Lundemose was Chairman at InteRNA Technologies BV.
Dr. Lundemose was Associate Director-Business Development at Novo Nordisk A from 1994 to 1998.
Dr. Lundemose was Director at Topotarget A in 2010.
Dr. Lundemose was Director at Display Systems Biotech As.
Dr. Lundemose was Director at OSI Pharmaceuticals (UK) Ltd. Dr. Lundemose was Director at Abzena (UK) Ltd. Dr. Lundemose was Director at OSI Investment Management GmbH.
Dr. Lundemose was Director at Adenium Biotech ApS.
Dr. Lundemose was Non-Executive Director at Abzena Ltd. from 2014 to 2016.
Dr. Lundemose was Independent Non-Executive Director at Macrophage Pharma Ltd. Dr. Lundemose was Executive Vice President at OSI Pharmaceuticals, Inc. in 2009.
Dr. Lundemose was Member at American Diabetes Association.
Dr. Lundemose was President at Prosidion Ltd. in 2009.
Dr. Lundemose earned a doctorate from the University of Aarhus.